Phibro Animal Health Corp. (PAHC)
35.30
+0.27
(+0.77%)
USD |
NASDAQ |
Sep 16, 16:00
35.29
-0.01
(-0.03%)
After-Hours: 20:00
Phibro Animal Health Enterprise Value : 2.139B for Sept. 16, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 16, 2026 | 2.139B |
| September 15, 2026 | 2.128B |
| September 14, 2026 | 2.165B |
| September 11, 2026 | 2.152B |
| September 10, 2026 | 2.191B |
| September 09, 2026 | 2.200B |
| September 08, 2026 | 2.220B |
| September 04, 2026 | 2.258B |
| September 03, 2026 | 2.272B |
| September 02, 2026 | 2.326B |
| September 01, 2026 | 2.263B |
| August 31, 2026 | 2.238B |
| August 28, 2026 | 2.235B |
| August 27, 2026 | 2.181B |
| August 26, 2026 | 2.171B |
| August 25, 2026 | 2.164B |
| August 24, 2026 | 2.139B |
| August 21, 2026 | 2.180B |
| August 20, 2026 | 2.134B |
| August 19, 2026 | 2.144B |
| August 18, 2026 | 2.112B |
| August 17, 2026 | 2.112B |
| August 14, 2026 | 2.101B |
| August 13, 2026 | 2.088B |
| August 12, 2026 | 2.078B |
| Date | Value |
|---|---|
| August 11, 2026 | 2.089B |
| August 10, 2026 | 2.092B |
| August 07, 2026 | 2.098B |
| August 06, 2026 | 2.147B |
| August 05, 2026 | 2.168B |
| August 04, 2026 | 2.191B |
| August 03, 2026 | 2.214B |
| July 31, 2026 | 2.180B |
| July 30, 2026 | 2.185B |
| July 29, 2026 | 2.206B |
| July 28, 2026 | 2.182B |
| July 27, 2026 | 2.136B |
| July 24, 2026 | 2.087B |
| July 23, 2026 | 2.088B |
| July 22, 2026 | 2.078B |
| July 21, 2026 | 2.080B |
| July 20, 2026 | 2.047B |
| July 17, 2026 | 2.058B |
| July 16, 2026 | 2.107B |
| July 15, 2026 | 2.075B |
| July 14, 2026 | 2.047B |
| July 13, 2026 | 2.045B |
| July 10, 2026 | 2.008B |
| July 09, 2026 | 2.020B |
| July 08, 2026 | 2.023B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Zoetis, Inc. | 37.80B |
| ANI Pharmaceuticals, Inc. | 1.925B |
| Corcept Therapeutics, Inc. | 11.77B |
| Veru, Inc. | 16.45M |
| Johnson & Johnson | 671.95B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 21.71M |
| Revenue (Quarterly) | 396.75M |
| Total Expenses (Quarterly) | 375.04M |
| EPS Diluted (Quarterly) | 0.5295 |
| Gross Profit Margin (Quarterly) | 33.68% |
| Profit Margin (Quarterly) | 5.47% |
| Earnings Yield | 6.90% |
| Operating Earnings Yield | 13.89% |
| Normalized Earnings Yield | 7.617 |